JUN and melanoma: Crucially, the result of this work, FAM‐HW33‐NLSTAT, was shown to reduce SK‐MEL‐28 melanoma cell viability through cJun depletion, validating the utility of this TBS workflow toward therapeutic antagonists of protein‐DNA interactions.